References
- Carlsson S., Hedner U., Nilsson I. M., Bergentz S.-E., Ljungqvist U. Kidney transplantation and fibrinolytic split products in serum and urine. Transplantation 1970; 10: 366
- Carlsson S., Hedner U., Nilsson I. M. Coagulation studies in patients with cancer. Acta Chir Scand 1973, in press
- Cliffton E. E., Grossi D. E. Fibrinolytic activity of human tumours as measured by the fibrin plate method. Cancer 1955; 8: 1146
- Colman R. W., Meyers A. R., Bloch K. J., Niewiarowski S., Thomas D. P. (1970) Patterns of fibrinogen degradation products in renal disease: A comparative study of three essays. I. Abstract XIII Internal Congr Haematology, Munich, 1970. Lehmann, München, 253
- Hedner U., Nilsson I. M. Clinical experience with determination of fibrinogen degradation products. Acta Med Scand 1971; 189: 471
- Larsson S. O., Hedner U., Nilsson I. M. Fibrinolytic split products in serum and urine in uraemia. Scand J Urol Nephrol 1971; 5: 234
- Merskey S., Kleiner G. J., Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood 1966; 28: 1
- Niléhn J.-E. Separation and estimation of “split products” of fibrinogen and fibrin in human serum. Thromb Diath Haemorrh 1967; 18: 487
- O'Meara R. A. Q. Coagulative properties of cancers. Irish J Med Sci 1958; 394: 474
- Peterson H. I. Experimental studies on fibrinolysis in growth and spread of tumour. Acta Chir Scand 1968, Suppl. 394
- Astedt B., Svanberg L., Nilsson I. M. Fibrin degradation products and ovarian tumours. Brit Med J IV 1971; 458